ACE and cardiovascular disorder: Trial evidence elsewhere has shown that in patients with established ACVD, medicines such as anti‐platelet therapy, ACE inhibitors, beta‐blockers and statins are cost‐effective in reducing the risk of subsequent cardiovascular disease (CVD) events.